Coronavirus Watchlist & More

Todos Medical, Ltd. TOMDF

The see-saw of market volatility persists with no end in sight. Traditional investing has become a fool’s errand in many, if not most, cases. The kind of opportunistic short term trading that we do is relatively intact, with the right targets and scenarios.

In this case, we caught TOMDF’s coronavirus news in the premarket yesterday, stating that the company had secured distribution agreements for testing kits in both the US and Isreal. After including it in our extended watchlist, the stock managed a very nice intraday gain. It traded up from a low of  0413, and reached a high of .08, which works out to an intraday upswing of 94%

Coronavirus Watchlist

While we do focus primarily on quick strike opportunities, it’s also worth it to mention a few plays that represent products and services that are high demand at the present time due to the fallout from COVID-19. If the report from the UK’s highly respected Imperial College is accurate, this global health crisis is only in its beginning stages, and will get much, much worse in the months ahead.

While neither these, nor any other plays are “corona-proof”, the effects may weigh less heavily on these stocks and those like them:


Extended Watchlist:

Expertly Timed Reversal

iBio, Inc. IBIO – Recap

Among those stocks that we have been tracking concurrently with the coronavirus outbreak in progress, is IBIO, which we just updated readers on in Friday morning’s report. We may be in line to see a better performance from stocks in general in contrast to last week’s historical market decline, which would lead to consolidation in stocks like IBIO, although it did manage to record an incredible new high Friday.

We had just recapped Thursday’s performance wherein the stock ran as high as .887, but Friday’s session took it to a whole new level. IBIO traded in a range from 1.50-3.40 for an intraday pop of 127%

Following our tag on Dec. 5th, the stock was trading for as little .189, and from there, Friday’s newly registered high represents an increase of 1699%

Innovation Pharmaceuticals, Inc. IPIX

We also want to watch IPIX, an OTCQB company which believes it has a scientific basis to believe that one of its preexisting treatments could be effective against coronavirus. We would suggest you read the PR outlining this in greater detail and keep IPIX on your radars. (>>View PR)


We also want to recap the performance of the SPY Calls we signaled on Friday morning, which will also continue to be in play for a potential market recovery this week.

We timed our flip-flop perfectly, having gone primarily with puts for our options ideas while the markets were in hysterics, and an intraday rebound provided for the following gain opportunities:

SPY 03/13 $298-301 Calls
$298: 5.67-9.41 (+66%)
$299: 5.44-8.45 (+55%)
$300: 4.65-9.32 (+100%)
$301: 4.54-9.00 (+98%)

Fresh Options Ideas:

JD Weekly $39.50-41.50 Calls

MTDR 04/17 $10-15 Calls
(Stock itself may be in play, extremely oversold)

Extended Watchlist: